For the Quarter Ending March 2026
Amphotericin B Prices in APAC
- In China, the Amphotericin B Price Index rose by 0.10% quarter-over-quarter, reflecting balanced supply modest exports.
- The average Amphotericin B price for the quarter was approximately USD 650000/MT FOB Shanghai basis.
- Amphotericin B Spot Price firmed as larger exporters absorbed reallocated volumes from constrained smaller fermenters.
- Amphotericin B Production Cost Trend rose on higher substrate prices and electricity tariffs affecting freeze-drying.
- Amphotericin B Demand Outlook is steady because routine hospital off-take and export tenders maintain consumption.
- Amphotericin B Price Forecast shows mild firmness ahead as inventories tighten and buyers secure shipments.
- Amphotericin B Price Index reflected thinner on-hand stocks and disciplined seller offers from vertically-integrated manufacturers.
- Ports operated; Amphotericin B Spot Price volatility remained limited by vessel coordination and terminal stocks.
Why did the price of Amphotericin B change in March 2026 in APAC?
- Environmental inspections intensified, constraining smaller producers' batches and redirecting orders to higher-priced integrated manufacturers thereby.
- Upstream substrate and electricity costs increased, raising Amphotericin B Production Cost Trend, pressuring margins thereby.
- Export enquiries from India and Brazil absorbed output, tightening inventories, supporting Amphotericin B Price Index.
Amphotericin B Prices in Europe
- In Germany, the Amphotericin B Price Index rose by 0.11% quarter-over-quarter, reflecting marginal supply tightness.
- The average Amphotericin B price for the quarter was approximately USD 650114.67/MT, according to trade sources.
- Amphotericin B Spot Price edged higher as air-freight delays constrained prompt cargoes, supporting the Price Index.
- Amphotericin B Price Forecast points to firmness amid elevated tariffs and Amphotericin B Production Cost Trend increases.
- Amphotericin B Demand Outlook stays muted as hospitals maintain contract call-offs, limiting spot market response this quarter.
- Inventories at distributors tightened near lower three-month range, influencing Amphotericin B Production Cost Trend and import parity.
- Export offers from Italy, Denmark and India firmed, elevating Amphotericin B Spot Price and the Price Index.
- Contractual procurement and price-inelastic hospital demand limited speculative buying, moderating Amphotericin B Price Index volatility.
Why did the price of Amphotericin B change in March 2026 in Europe?
- Elevated utility tariffs and stricter GMP compliance increased manufacturing costs, prompting producers to lift dollar offers.
- Lengthened temperature-controlled air-freight lead-times tightened prompt availability, raising reliance on higher-cost shipments and insurance premiums.
- Hospital procurement stayed price-inelastic with stable tenders, limiting demand response despite marginal import cost pressures.
Amphotericin B Prices in North America
- In the USA, the Amphotericin B Price Index rose by 0.11% quarter-over-quarter, reflecting balanced imports.
- The average Amphotericin B price for the quarter was approximately USD 650,156.67/MT, from importer transactions.
- Amphotericin B Spot Price tightened in March as freight rose, lifting the Price Index modestly.
- Amphotericin B Price Forecast shows modest gains driven by higher logistics and steady hospital demand.
- Amphotericin B Production Cost Trend remained stable for fermentation inputs, though logistics raised landed costs.
- Amphotericin B Demand Outlook stable as hospitals held contracted volumes, keeping spot buying subdued throughout.
- Distributor inventories remained lean and export allocations limited, supporting the Amphotericin B Price Index strength.
- Exporters operated with routine maintenance trimming slots, influencing Amphotericin B Spot Price and CFR offers.
Why did the price of Amphotericin B change in March 2026 in North America?
- Rising trans-Pacific freight in March increased landed costs for imported Amphotericin B, applying upward pressure.
- Steady export production but cautious batch releases trimmed available volumes, tightening supply for U.S. distributors.
- Hospital procurement remained firm due to clinical need and contract cycles, limiting downward price momentum.
For the Quarter Ending December 2025
Amphotericin B Prices in North America
- In USA, the Amphotericin B Price Index rose by 0.56% quarter-over-quarter, reflecting constrained supply pressures.
- The average Amphotericin B price for the quarter was USD 649446.67/MT on CFR Houston basis.
- Amphotericin B Spot Price firmed as Indian exporters limited shipments after sterility re-tests reduced volumes.
- Amphotericin B Price Forecast suggests modest gains from import constraints and institutional purchasing demand support.
- Amphotericin B Production Cost Trend edged higher as sterile processing and precursor materials pushed prices.
- Amphotericin B Demand Outlook firm as hospitals and formulators replenish stocks ahead of seasonal pressures.
- Amphotericin B Price Index advanced despite lower ocean freight, because cold-chain air transport remained costly.
- Domestic fermentation plants operated normally, covering one-third of demand, sustaining import dependence and price resilience.
Why did the price of Amphotericin B change in December 2025 in North America?
- Reduced Indian export volumes after batch re-tests tightened spot availability, nudging CFR Houston prices higher.
- Cold-chain airfreight costs stayed elevated despite falling ocean rates, limiting full logistical relief for imports.
- Sustained hospital demand and distributor restocking ahead of winter supported modest Amphotericin B price increases.
Amphotericin B Prices in APAC
- In China, the Amphotericin B Price Index rose by 0.52% quarter-over-quarter, driven by tighter supply.
- The average Amphotericin B price for the quarter was approximately USD 649333.33/MT, weighted shipment average.
- Stable factory runs supported Amphotericin B Spot Price stability, while freight prevented deeper downward adjustment.
- Inventory drawdowns at formulators tightened the Amphotericin B Price Index, reducing availability for urgent orders.
- Export demand remained routine, shaping the Amphotericin B Demand Outlook as modest and broadly stable.
- Higher feedstock, freight costs nudged the Amphotericin B Production Cost Trend upward, supporting seller margins.
- Analysts expect the Amphotericin B Price Forecast to show upticks amid freight volatility, scheduled maintenance.
- Domestic plant reliability and steady hospital procurement kept the Amphotericin B Price Index broadly balanced.
Why did the price of Amphotericin B change in December 2025 in APAC?
- Intermittent factory downtime and flooding constrained intermediate feedstock supply, tightening amphotericin availability for December shipments.
- Air freight surges and mid-quarter GRIs raised logistics costs, prompting producers to protect margins modestly.
- Steady hospital procurement and routine export orders maintained demand, preventing sharp volatility despite cost pressures.
Amphotericin B Prices in Europe
- In Germany, the Amphotericin B Price Index rose by 0.51% quarter-over-quarter, reflecting tightened imports and logistics pressures.
- The average Amphotericin B price for the quarter was approximately USD 649411.67/MT, reported by trade sources.
- Amphotericin B Spot Price remained firm in December as import offers reflected elevated energy and compliance costs.
- Amphotericin B Price Forecast indicates modest, steady appreciation supported by seasonal restocking and manageable logistical constraints.
- Amphotericin B Production Cost Trend shows upward pressure from higher electricity tariffs and testing compliance expenses.
- Amphotericin B Demand Outlook remains stable as hospitals follow tenders, limiting discretionary procurement and volume growth.
- Amphotericin B Price Index movement was tempered by steady inventories and import schedules from Italy, Denmark, and India.
- Exports from Southern Europe and Asia operated normally, keeping landed costs stable while modest replacement-cost pass-through persisted.
Why did the price of Amphotericin B change in December 2025 in Europe?
- Import tightening and re-routing raised landed costs, reducing readily available surplus cargo in the German market.
- Higher electricity tariffs and GMP testing compliance increased production and replacement costs for imported Amphotericin B.
- Seasonal hospital restocking and cautious forward procurement absorbed surplus stocks, supporting modest upward price momentum.
For the Quarter Ending September 2025
North America
- In the USA, the Amphotericin B Price Index rose by 0.25% quarter-over-quarter, due to frontloading.
- The average Amphotericin B price for the quarter was approximately USD 645802/MT, reported by sources.
- Accelerated imports tightened inventory, supported the Amphotericin B Spot Price, reducing availability across distribution channels.
- Rising handling and shipping expenses influenced the Amphotericin B Production Cost Trend, pressuring supplier margins.
- Forward procurement concentrated purchases, shaping the Amphotericin B Demand Outlook and sustaining near term prices.
- Manufacturer release pacing with cautious distributor stocking tempered the Amphotericin B Price Index and volatility.
- Models and steady import activity inform the Amphotericin B Price Forecast, indicating modest upward adjustments.
- Container rate increases and port congestion raised costs, affecting Amphotericin B supply chains and margins.
Why did the price of Amphotericin B change in September 2025 in North America?
- Advanced buying ahead of tariff uncertainty increased near-term demand, tightening available inventories and pressuring prices.
- Inflationary pressures and elevated logistics handling costs raised production, distribution costs, supporting modest price increases.
- Ports experienced congestion and container cost upticks, slowing flows and prompting procurement to secure supply.
APAC
- In China, the Amphotericin B Price Index rose by 0.30% quarter-over-quarter, led by export frontloading.
- The average Amphotericin B price for the quarter was approximately USD 646000.00/MT, reflecting modest export-led firming.
- Amphotericin B Spot Price subdued as suppliers tightened availability while Amphotericin B Price Index steadied.
- The Amphotericin B Price Forecast indicates modest gains amid logistical cost increases and producer discipline.
- Amphotericin B Production Cost Trend reflects higher freight and weather costs, mildly pressuring producer margins.
- Amphotericin B Demand Outlook is cautiously positive due to export restocking and steady downstream formulation.
- Exports and constrained vessel space tightened availability, prompting firms to prioritize contractual shipments over spot sales.
- Major exporters maintained measured operating rates, keeping inventories balanced and limiting price volatility into the season.
Why did the price of Amphotericin B change in September 2025 in APAC?
- Frontloaded export shipments ahead of tariff suspension increased demand, tightening supply and supporting price rises.
- Rising ocean freight and weather disruptions elevated production costs, exerting upward pressure on domestic pricing.
- Manufacturers maintained cautious operating rates and inventory discipline, moderating supply responses and stabilizing the market.
Europe
- In Germany, the Amphotericin B Price Index rose by 0.30% quarter-over-quarter, driven by port congestion.
- The average Amphotericin B price for the quarter was approximately USD 646094.33/MT on CFR Hamburg.
- Supply tightness and early restocking kept Amphotericin B Spot Price supported despite freight cost increases.
- Amphotericin B Price Index stability reflected managed logistics, modest surcharges, and disciplined distributor procurement behavior.
- Amphotericin B Price Forecast shows gradual modest increases projected through Q4, assuming logistics steadily normalize.
- Amphotericin B Production Cost Trend saw upward pressure from higher freight and inland transport costs.
- Amphotericin B Demand Outlook remains steady as hospitals and wholesalers cautiously restock, avoiding bulk purchases.
- Inventory drawdowns and constrained imports limited spot availability, supporting the short-term Amphotericin B market equilibrium.
Why did the price of Amphotericin B change in September 2025 in Europe?
- Port congestion and inland transport constraints delayed shipments, tightening supply and increasing procurement uncertainties premiums.
- Rerouted shipping and higher freight increased landed costs significantly, exerting upward pressure on market offers.
- Buyers preemptively restocked amid uncertain delivery schedules, reducing available spot volumes and supporting modest increases.
For the Quarter Ending June 2025
North America
- The Price Index of Amphotericin B in the USA declined by 6.66% in April 2025 due to frontloaded imports, tariff uncertainty, and a build-up in supplier inventories.
- The most significant price decrease occurred in April, driven by subdued demand and buyers reducing procurement amidst excess stock and trade ambiguity.
- The Amphotericin B Spot Price continued to soften in May, slipping by 0.31%, as regulatory changes and cautious buyer sentiment restricted fresh orders.
- A temporary easing of U.S.–China trade tensions in mid-May created only marginal impact, with importers still limiting purchase volumes due to tariff volatility.
- May's Demand Outlook was muted as buyers awaited clarity on pricing reforms introduced by a new executive order linking U.S. drug prices to global benchmarks.
- In June, the Price Index rose slightly by 0.20%, supported by anticipatory buying and forward shipments by importers during the extended trade truce.
- June saw steady domestic demand as pharmaceutical firms advanced procurement to secure inventory before further cost surges.
- The Amphotericin B Production Cost Trend reflected mild inflationary pressures, leading buyers to hedge against expected Q3 increases.
- Strategic stockpiling during the quarter helped stabilize prices, despite an overall cautious procurement strategy.
- The Amphotericin B Price Forecast for early Q3 suggests marginal increases due to inventory tightening and unresolved trade policy risks.
China
- The Price Index for Amphotericin B in China fell consistently through April and May before a marginal recovery in June, with Spot Prices at USD 645,000/MT (April), USD 643,000/MT (May), and USD 644,200/MT (June).
- In April 2025, the most significant price drop of -6.66% was recorded due to weak domestic consumption, sluggish global orders, and mounting inventories amid port congestion and U.S. tariff impositions.
- A declining Product Demand Outlook was evident in April, especially from U.S. buyers who canceled or delayed shipments due to a steep 145% tariff.
- China's manufacturing PMI dropped to 49.0 in April, reflecting the worst contraction in over a year, affecting Product Production Cost Trend and factory outputs.
- In May, the Price Index continued to fall by -0.31%, driven by order stagnation, rising inventory levels, and cautious global procurement activity.
- Exporters lowered prices in May to ease backlogs, facing declining new export orders despite a brief tariff relief mid-month.
- The extended Labor Day holiday in May further weakened activity, limiting short-term demand recovery.
- June 2025 saw a slight Price Index rebound of +0.19%, supported by a temporary export surge after a 90-day U.S. tariff suspension.
- Shipping lines raised freight rates from June 1, prompting advanced ordering and enabling suppliers to lift Spot Prices modestly.
- Despite gains in June, uncertainty remains around long-term Amphotericin B Price Forecast, as tariff volatility and cautious production adjustments persist.
Germany
- In April 2025, the Amphotericin B Price Index in Germany declined sharply by 6.66%, primarily due to a supply glut caused by the diversion of US-bound shipments into Europe after the imposition of tariffs by the U.S., saturating the German market with surplus inventory.
- The most significant price drop occurred in April as European buyers had pre-stocked inventories ahead of the Labour Day holiday (May 1–5). This early stocking, combined with weak demand and a lack of new cargo intake, drove down the Product Spot Price significantly.
- Throughout April, imports from Asia and ample shipping capacity ensured continuous supply, maintaining an oversupplied market. Buyers refrained from additional purchases, resulting in a persistently low Product Demand Outlook.
- In May 2025, the Price Index fell further by 0.31%, sustained by high inventory levels and weak retail activity under inflationary pressures. Buyers postponed orders due to logistical uncertainties and a cautious procurement stance.
- The downtrend in May was mainly influenced by post-tariff realignments that rerouted Chinese pharmaceutical cargoes to Europe. This extended oversupply, forcing suppliers to adopt competitive pricing strategies to clear stock.
- May’s inland logistics were further disrupted by worsening port congestion at major hubs like Hamburg and Rotterdam. Despite these challenges, upstream availability remained high, reducing any significant Product Price Forecast recovery.
- In June 2025, the trend reversed slightly with a 0.19% increase in the Price Index, driven by worsening port congestion and Rhine River disruptions, which delayed inbound shipments and prompted early restocking.
- The June price increase was primarily due to tightening supply chains, with importers reacting to prolonged shipping delays by ordering in advance, creating temporary Product Production Cost Trend pressures due to logistical rerouting.
- Despite easing inflation (2% in June), downstream buyers such as pharmacies and hospitals maintained cautious inventory policies. The Product Demand Outlook remained stable but subdued, contributing to a modest pricing uptick.
- Over Q2 2025, Germany’s Amphotericin B market experienced a net negative Price Index trend, with the April glut being the primary deflationary driver, while logistical constraints in June partially stabilized the market.
